Home
Resources
Follow portfolio news
...

Flo Health can detect endometriosis 50% faster

Published on
5/3/2026
Amended on
13/4/2026
0
minute(s)
Odyssey 2021
Flo Health can detect endometriosis 50% faster
Flo Health, the world’s most downloaded period tracking app, has been improving women’s health for 10 years. The London-based unicorn, which is part of the Vintage FPCI Altaroc Odyssey portfolio, has just released the results of a study suggesting that, with proper tracking on the app, endometriosis could be detected four years earlier.
By
Antoine Orsoni
Antoine Orsoni
Flo Health can detect endometriosis 50% faster
This article has been automatically translated. Please excuse any inaccuracies or translation errors.
Dieser Artikel wurde automatisch übersetzt. Bitte entschuldigen Sie etwaige Ungenauigkeiten oder Übersetzungsfehler.
This article has been automatically translated. We apologize per inaccuracies or translation errors.

Currently, it takes an average of seven years for women to receive a diagnosis of endometriosis. Endometriosis is a chronic gynecological condition in which tissue similar to that lining the inside of the uterus grows outside of it, most often in the pelvic area. Endometriosis can cause very intense and debilitating menstrual pain, but also chronic pelvic pain outside of menstruation, pain during sexual intercourse, digestive problems such as bloating or constipation, urinary pain, and deep and persistent fatigue.

A new study, conducted by scientists at Flo Health, researchers at the London School of Hygiene & Tropical Medicine, and experts at the York Health Economic Consortium, shows encouraging results. The study found that when tools such as the Endometriosis Symptom Checker (built into the app) are used, they could reduce the time to diagnosis by more than four years, or more than 50% earlier.

Although it affects approximately 190 million women worldwide, endometriosis remains largely under-recognized within healthcare systems. On average, women can spend up to seven years navigating fragmented care pathways with limited understanding of their symptoms, while living with severe menstrual pain and chronic pelvic pain, before receiving a diagnosis. Enabling diagnosis up to four years earlier could significantly mitigate the consequences of late detection and reduce the long-term impact of the disease.

"Endometriosis can profoundly disrupt women's lives, yet many spend years searching for answers in a system that has not always been designed to connect the patterns they observe over time. This study examines how digital tools can help women better recognize their symptoms and bring clearer information to their interactions with healthcare professionals. While these tools do not provide a diagnosis, they promote earlier awareness and more informed decisions, thereby changing the trajectory of their care and their lives," said Dr. Anna Klepchukova, Chief Medical Officer at Flo Health. In addition, by detecting the disease earlier, patients could save themselves approximately $5,000 in long and costly care.

Flo Health, recently awarded by Google Play as the best app for smartwatches, continues to establish itself as the digital benchmark for the health and well-being of tens of millions of women around the world.

Other episodes on this topic

Explore our content collections, which bring together different formats around a single subject/issue/theme.
No articles in this category yet.
No items found.
Europe
Healthcare
Welcome to Altaroc
To provide you with a tailored experience, please complete your profile.
Your profile
country of tax residence
Select
choosenCountry
Preferred language
Select
choosenLang
YOUR INVESTOR PROFILE
Financial intermediary or professional investor
Financial advisors, wealth managers, private bankers, or any other investment service providers.
Qualified Investor or Altaroc Investor
Experienced investor or Altaroc investor
Private investors who have already invested with Altaroc or who have a minimum investment capacity of €100,000.
Private investors who have previously invested in Altaroc who have a minimum investment capacity of 200,000 euros.
Non-professional (retail) investor
Individual investors with an investment capacity below €100,000.
Retail investors with an investment capacity of less than 200,000 euros.
Institutional investor
Pension funds, retirement schemes, asset management companies, and single-family offices.
Scroll down to accept General Terms and Conditions
The webpage you are trying to access is not available in your country.